Navigating Nipah virus: Insights, challenges, and recommendations

Authors: Muhammad Hassan Hafeez, Hafsa Ajmal, Amna Nadeem, Shehroze Tabassum, Aymar Akilimali, *

Year: 2025

Journal: New Microbes and New Infections

Summary

This paper discusses the challenges posed by Nipah virus, a zoonotic pathogen, focusing on its diverse strains, recurrent outbreaks, diagnostic limitations, and the need for therapeutic advancements.

Key Findings

• Nipah virus (NiV) is a biosafety level 4 and category C pathogen belonging to the Paramyxoviridae family and Henipavirus genus
• NiV infections range from mild to severe, with an incubation period of 4–14 days and initial symptoms including fever, headache, and respiratory distress
• Notably, NiV-MY proves more virulent than NiV-BD, highlighting genotypic variations

Methodology

• Study Type: Mini-Narrative Review

Topics

Epidemiology, Virology

Relevance

The paper discusses the urgency for comprehensive biosecurity measures and early detection systems to address the evolving landscape of Nipah virus, emphasizing the need for collaborative efforts to mitigate its impact on public health.

Source

View the entire paper: File:Main (2).pdf